Clinical Trial Update: Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis [Phase 1]

View source ↗

Summary

Phase 1 safety study of LY3114062 in participants with inflammatory arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Arthritis

Drugs mentioned

• LY3114062 (LY3114062)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Inflammatory Arthritis | Phase 1 | Status: COMPLETED